The use of LC–MS in early discovery stage-workflows enables rapid screening of large compound libraries for activity against biological targets. This technique can accelerate the early drug screening process, identifying compounds with potential – known as drug leads – and reduce time spent on discovering inefficient leads.
Thank you to everyone who participated in this survey. This survey has now closed. Please keep an eye on the Spotlight pages for an infographic with the results. The winner of the $25 Amazon voucher will be contacted privately.